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Abstract.  Calpactins  are a  family of related Ca§247  - 
ulated cytoskeletal proteins.  To analyze the expression 
and cytoskeletal association of calpactins  we raised 
monoclonal  antibodies  with  specificity for the heavy 
or light chains  of calpactin  I  or to calpactin  II.  Com- 
parison  of the tissue distribution  of calpactin  I heavy 
and light chains by Western blots revealed that these 
subunits are coordinately  expressed.  Both soluble and 
cytoskeletal forms of the heavy chain  of calpactin  I 
were detected in human  fibroblasts whereas only a 
soluble pool of calpactin II was found.  These two 
forms of the calpactin I  heavy chain differed both in 
their state of association with the light chain and in 
their rate of turnover.  Both the soluble pool of the cal- 
pactin I  heavy chain and calpactin  II turned over three 
to four times  faster than the cytoskeletal pool of heavy 
and light chains.  Immunofluorescence  microscopy re- 
vealed that the calpactin I  light chain  was present ex- 
clusively in the cytoskeleton whereas  the calpactin  I 
heavy chain distribution  was more diffuse.  No differ- 
ence in the amount of light chain or the cytoskeletal 
attachment  of phosphorylated  calpactin I  heavy chain 
was found in Rous sarcoma virus-transformed  chick 
embryo fibroblasts compared with their normal  coun- 
terpart.  The antibody to the light chain of calpactin  I 
was microinjected  into cultured  fibroblasts and kidney 
epithelial  cells.  In many cases antibody clustering  was 
observed with the concomitant aggregation  of the as- 
sociated calpactin  I heavy chain.  The distribution  of 
fodrin and calpactin II in injected cells remained  un- 
changed.  These results are consistent with the exis- 
tence of two functionally  distinct pools of calpactin I 
which differ in their association with the cytoskeleton. 
C 
ALPACTINS comprise a  family of Ca§247  pro- 
teins which interact with phospholipids and the cyto- 
skeletal proteins actin and spectrin (15, 16, 21, 22, 24, 
50). Calpactin I (also termed p34, p36, or p39) is a major 
substrate of tyrosine protein kinases (11, 12, 34, 46) and is 
found in cells as either a 38-kD monomer or a 90,000 molec- 
ular mass tetramer of heavy (38 kD) and light (11 kD) chain 
subunits (13, 16). The  ll-kD light chain was found to share 
amino acid sequence homology with the Ca++-binding  pro- 
teins termed S-100 (18, 25, 32). In addition,  recent reports 
have documented homology between the calpactin light chain 
and the predicted sequence of a growth factor-inducible gene 
termed 2A9 (3) as well as the cystic fibrosis antigen (9). The 
function of the calpactin  light chain is unclear and during 
evolution it has apparently  lost the Ca++-binding  function 
expressed in S-100 (18, 22). It has been suggested that the cal- 
pactin light chain may serve a regulatory role since it binds 
to the same region of the calpactin heavy chain that is phos- 
phorylated by the tyrosine kinases (26, 36). Indeed, recent 
evidence has shown that some serine phosphorylations in the 
amino terminus of the heavy chain will prevent light chain 
binding (35). 
A second 39-kD substrate of the epidermal growth factor 
receptor tyrosine kinase has been identified (14, 43). Initially 
termed p35, we refer to this protein as calpactin II, since it 
is  known to be a  Ca  ++-, phospholipid-,  and  actin-binding 
protein and related to calpactin I  (7, 21, 27). 
The cDNAs encoding both the heavy chains of calpactins 
I and II have been cloned and sequenced (33, 38, 49, 51). The 
calpactins were first thought to be lipocortins, anti-inflamma- 
tory, secreted proteins that bind to and inhibit phospholipase 
Az (51).  More recent investigations  have revealed that the 
inhibition  of phospholipase  A2 is the result of nonspecific 
shielding of phospholipids by calpactins (6). In addition, cal- 
pactins  are  clearly  abundant  intracellular  proteins  and 
numerous studies have shown that calpactin I is present un- 
der the membrane in a cytoskeletal meshwork partially over- 
lapping  the distribution  of spectrin  in the  same cells (see 
below). 
The cytoskeleton is a  term used to refer to the cellular 
framework  that  includes  microtubules,  intermediate  fila- 
ments,  and  microfilaments.  Operationally,  investigators 
generally refer to those proteins insoluble in nonionic deter- 
gent solution under a defined set of buffer conditions to be 
cytoskeletal,  although  clearly  the  nucleus  and  other  or- 
ganeUes are found in this detergent-insoluble residue.  The 
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insoluble residue in fibroblasts (5, 30, 40, 45). Furthermore 
in cells fixed before extraction, immunofluorescence micros- 
copy revealed that calpactin I heavy chain was found  just un- 
der the membrane, although with a notable lack of staining 
in  those regions of the cells where actin bundles  (stress 
fibers) were also present (45). In intestinal epithelial cells the 
heavy chain of calpactin I  is  found in the terminal web 
regions  of the  brush  border  (16, 28,  31),  a  specialized 
microfilament-rich region of  the cell from which other mem- 
brane systems and organelles are excluded. Consistent with 
this distribution calpactin is known to bind to the cytoskeletal 
proteins actin and spectrin in vitro (16, 24),  albeit at high 
Ca  ++ levels  (17). The Ca  ++ sensitivity of calpactin can be 
shifted from the millimolar to the micromolar level by an- 
ionic phospholipids (20, 22). It is not known whether these 
in vitro associations reflect the targets in the cell, yet clearly 
the available data point to association with some cellular 
structure(s) in close proximity to the plasma membrane. 
The functional significance of two forms of calpactin I 
(monomer vs. complex) is unknown. To study the distribu- 
tion of individual subunits of the calpactin family we have 
raised monoclonal antibodies to the heavy and light chains 
of calpactin I and the 39-kD calpactin II. The antibodies de- 
tect calpactin subunits in Western blots, immunoprecipita- 
tion, and immunofluorescence microscopy. We focused on 
the synthesis and distribution of calpactin in normal human 
fibroblasts and the results suggest that the light chain of cal- 
pactin I is tightly associated with the membrane skeletal form 
of calpactin I. 
Materials and Methods 
Protein and Antibodies 
Calpactins I and II were isolated from bovine lung essentially as described 
(27).  Polyclonal antibodies to calpactin were as in Glenney et al. (27), and 
to fodrin were as in Glenney and Glenney (23). Rabbit antibodies to phos- 
photyrosine were a generous gift from Dr. Mark Kamps (Salk Institute). For 
monoclonal antibodies, the calpactin I complex of subunits was used as im- 
munogen in BALB/c mice (37) to the calpactin I heavy and light chain. Cal- 
pactin II, which has been shown to be identical by sequence to p35 and 
lipocortin (27),  was injected separately in other mice. 
The protocol for injections and screening of hybridoma will be provided 
in detail elsewhere. Briefly,  hybridomas were screened first by an ELISA 
and second by Western blots using total bovine lung extracts. Hybridomas 
positive by these two assays were cloned twice (or until upon rescreening 
all of the subclones were positive) by limiting dilution. 
Western Blots 
Cells and tissues were used for Western blotting by a modification of  a previ- 
ous method (19). Normal and Rous sarcoma virus-transformed chick em- 
bryo fibroblasts were provided by Dr. Bart Sefion (Salk Institute). Bovine 
tissues were frozen on dry ice at the slaughter house and subsequently 
homogenized in  a  blender  (Waxing  Products Div.,  Dynamic  Corp.  of 
America, New Hartford, CT) for 1-2 min in 10 vol of H20. Aliquots were 
either used directly for protein determination (BCA assay; Pierce Chemical 
Co., Rockford, I-L) or added to an equal volume of two times concentrated 
sample buffer and boiled for 5 rain. For Western blots, 25 gg of total cell 
protein was loaded per lane and resolved on a  13% acrylamide SDS gel. 
Since we found that the light chain adsorbs very poorly to nitrocellulose, 
we modified  the transfer conditions to include 40% methanol and then read- 
justed the pH to 8.6~ Transfer to nitrocellulose was performed at 1 A for 1 h 
(using an electrophoretic transfer apparatus from Hoefer Scientific Instru- 
ments, San Francisco, CA). Blots were dried in a 65~  vacuum oven for 
15 rain, stained with India ink for 4-5 h, and after blocking, incubated in 
hybridoma culture supernatant diluted 1:2 with MTA buffer (19). Blots were 
incubated with first antibody overnight, washed, and incubated with 125I- 
conjugated goat anti-mouse IgG (Sigma Chemical Co., St. Louis, MO) for 
1-2  h, washed 30 min, and exposed to Kodak AR-5 film for 2-24 h. 
Metabolic Labeling and Immunoprecipitation 
Pulse-chase experiments followed byselective extraction and immunopre- 
cipitation were performed as follows. Human fibroblasts (21) were plated 
into 6-well tissue culture plates and grown in DME supplemented with 10% 
FBS and the following morning were preincubated 30 min with DME with- 
out methionine and substituting dialyzed fetal  bovine serum. Cells were 
then pulse-labeled with the same media containing 200 gCi [3~Slmethio- 
nine (ICN Biomedicals Inc., Irvine, CA) for 2 h. The media was removed 
and after rinsing with PBS was replaced with DME supplemented with 1 
mM unlabeled methionine. Cells were harvested at the specified chase 
times. The media was removed and cells were extracted with sequential 250 
BI aliquots of 10 mM imidazole (pH 7.3),  75 mM KC1, 2 mM MgCt2, 0.5 
mM CaC12, 1 mM NAN3, 0.5% Triton X-100 (buffer 1) for 2 min at 4~ 
The residual cytoskeleton was then extracted with 500 Ixl of 0.5 % SDS, 2 
mM EDTA (buffer 2) for 5 min at room temperature. The two extractions 
were then adjusted with 500 B1 of the opposite buffer, and frozen at -70~ 
until all time points were collected. Samples were thawed and centrifuged 
at 10,000 rpm for 15 min at 4~  Each sample was divided into three equal 
parts, adjusted to 1 ml with RIPA buffer (20 mM NaPO4, pH Z5, 500 mM 
NaC1, 5 mM EDTA, 1% NP-40, 0.5% deoxycholate, 0.1% SDS). First and 
second extractions were combined for immunoprecipitation with anti-light 
chain and anti-calpactin II  antibodies.  Hybridoma culture  supernatants 
were added and the samples were incubated at 4~  for 4 h. Goat anti-mouse 
second antibody was then added (10 B1 of 1 mg antibody/nil; Sigma Chemi- 
cal Co.) and further incubated 1 h at 4~  Washed Pansorbin (25 I~1 of 10% 
solution; Catbiochem-Behring Corp., La Jolla, CA) was then added and the 
tubes rotated end over end for 30 min. The Pansorbin was collected by cen- 
trifugation, washed three times in RIPA buffer, and the antigen was eluted 
with SDS-PAGE sample buffer.  Samples were analyzed by SDS-PAGE and 
gels were treated with Enlighming (New England Nuclear,  Cambridge, 
MA), dried, and exposed to preflashed x-ray film. The relative amount of 
radioactivity remaining at different chase times was determined by scanning 
the autoradiograms.  Each  experiment was  repeated four times and  the 
results were averaged. 
Immunofluorescence Microscopy 
Human fibmblasts, grown on glass coverslips, were either directly fixed and 
permeabilized with methanol/acetone (1:1) at -20~  or extracted 5 min at 
4~  with the cytoskeletal-stabilizing buffer (30) before methanol/acetone 
fixation. Coverslips were air dried and incubated with a mixture of culture 
supernatant plus  affinity-purified antibodies  to  calpactin or  fodrin (20 
gg/ml). Controls, omitting one of the first antibodies, were always included 
in parallel. After incubating 45 rain at 37~  coverslips were washed and 
incubated with aff nity-purified second antibodies (fluoresceine-conjugated 
goat anti-mouse and rhodamine-conjugated goat anti-rabbit). After incuba- 
tion with secondary antibody for 1 h at 37~  coverslips were washed and 
viewed in a  Nikon optiphot microscope equipped with epi-illumination. 
Photographs were taken on Ilford XP-1 or Kodak tmax 400 film using an 
ASA of 400 for fluorescein and 800 for rhodamine. 
Antibody to the calpaetin I light chain (I148) was microinjecl~xl into live 
fibroblasts or kidney cells (Madin-Daxby bovine kidney, [MDBK]; Ameri- 
can Type Culture Collection, Rockville, MD) essentially as described in 
Mangeat and Burridge (42).  Monoclonal IgG was purified by ammonium 
sulfate fractionation (50%), gel filtration on sephamse 4BCL, and ion ex- 
change chromatography (FPLC, mono Q), and the purity checked by SDS- 
PAGE and Coomassie staining. The monoclonal IgG at 5 mg/ml was in- 
jected into randomly selected cells that were then returned to culture for 
various times, rinsed in PBS, fixed, and treated for immunofluorescence 
microscopy as above.  The injected antibody was visualized with a fluores- 
cein-conjugated goat anti-mouse second antibody, and cells were counter- 
stained with rabbit polyclonal antibodies, and rhodamine-conjugated goat 
anti-rabbit second antibody. 
Results 
Homogeneous bovine calpactin I (as a complex of heavy and 
light chains) and calpactin II were used as immunogens for 
1. Abbreviation  used in this paper:  MDBK, Madin-Darby bovine kidney. 
The Journal  of Cell Biology,  Volume 105, 1987  2112 Figure  1.  Reactivity of monoclonal antibodies to calpactin I heavy and light chains and calpactin II in Western blots of isolated protein 
and fractionated human fibroblasts. Calpactin I complex of heavy and light chains (a), calpactin II (b), or human fibroblasts that had been 
separated into soluble (c) and cytoskeletal (d) fractions were resolved on 13 % acrylamide gels, and the protein transferred to nitrocellulose. 
The nitrocellulose membranes were stained for protein with India ink (left)  and further incubated with monoclonal antibodies (panel 1) 
Iip29 (to calpactin II), (panel 2) 1186, or (panel 3) 1148 (to the heavy and light chains, respectively, of calpactin I). Reactivity was then 
assessed using ~25I-labeled  second antibody followed by autoradiography (right).  Arrows on the sides of the stained blots and autoradio- 
graphs were made with radioactive ink to allow precise alignment of the two images. 
the production of monoclonal antibodies in BALB/c mice. 
The primary assays for detection ofanti-calpactin antibodies 
involved ELISA assays  followed by screening on Western 
blots. Those hybridomas that were strongly positive by both 
assays were selected and cloned twice by limiting dilution. 
In the present report, we will restrict ourselves to the analy- 
sis of one antibody reactive against each subunit. All three 
antibodies  reacted with the isolated proteins displayed on 
Western blots  (Figs.  1 and 2).  The immunoreactive band 
could unambiguously be assigned to the major India ink- 
stained protein bands in blots that were stained with India ink 
for protein before their use in Western blots (Fig.  1). Anti- 
bodies to calpactin I did not cross react with calpactin II and 
vice versa. Two higher molecular mass bands were reactive 
with the anti-calpactin I  antibodies in samples of purified 
protein (Fig.  1 left),  which probably represent aggregates of 
calpactin subunits. Since these were never observed in sam- 
ples of total cell protein (Figs.  1 and 2) we did not further 
pursue the identity of these bands.  Strongly reactive bands 
corresponding to the 38-kD calpactin I, the 39-kD calpac- 
tin II, or the ll-kD calpactin I light chain were detected in 
total lysates of both human cells and bovine tissues (Figs.  1 
and 2). 
To analyze the distribution of the calpactin I heavy and 
light chains in various tissues, the antibodies were used on 
duplicate Western blots of total bovine tissues and compared 
with standards of known amounts of protein. As shown in 
Fig. 2, this assay was quite sensitive since both heavy and 
light chains could be easily detected in a sample of 4 ng of 
the unfractionated calpactin I complex. The tissue distribu- 
tion of both the heavy and light chains were essentially iden- 
tical. The highest level of both was found in lung and intes- 
tine (Fig.  2),  two sources that have been used as starting 
material to purify the calpactin I complex (16, 27). Neither 
calpactin subunit was detectible in red blood cells and both 
were present at very low levels in liver and brain tissue. This 
would  also  indicate that  antibodies  to  the calpactin  light 
chain do not recognize the S-100 proteins, since these pro- 
teins are expressed at high levels in brain (1,  10). 
Antibodies to the calpactin I heavy and light chains and 
calpactin II all recognized the homologous proteins in human 
cells (Figs. 1 and 2 k). This allowed us to analyze the subcel- 
lular distribution and turnover of  calpactins in normal human 
diploid fibroblasts. 
The cytoskeletal association of proteins can be detected 
biochemically by their relative insolubility in nonionic deter- 
gent (see Introduction). To determine the cytoskeletal associ- 
ation of calpactin subunits human fibroblasts were extracted 
briefly with a mild detergent solution, fractionated into de- 
tergent soluble and insoluble pools, and analyzed by Western 
blots (Fig.  1). A marked difference in the behavior was de- 
tected by the three antibodies. Whereas >80% of calpactin 
II is soluble upon brief extraction, only 50%  of the heavy 
chain and <10% of the light chain of calpactin I was extracti- 
ble under these conditions. This suggested that two pools of 
calpactin,  which differ in  their association with the cyto- 
skeleton, exist in human fibroblasts. 
We examined the turnover rate of soluble and detergent- 
extractable calpactin I heavy chain and compared it with the 
turnover rate of the light chain and calpactin II. As shown 
in Fig. 3, a dramatic difference was observed in the half-life 
of soluble and cytoskeletal forms of the calpactin I  heavy 
chain. The soluble pool turned over with a half-life of 15 h, 
whereas the insoluble pool lagged far behind with a half-life 
of"~40-50 h. By comparison, the calpactin I light chain had 
a  relatively long half-life (50-60 h) and calpactin II had a 
shorter half-life (15 h). 
Anti-light chain antibodies were used in immunofluores- 
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calpactin I heavy chain and light chain by Western 
blotting with monoclonal antibodies to the indi- 
vidual subunits. 25 gg of total protein from bovine 
spleen (a), lung (b), intestine (c), adrenal gland 
(d), red blood cells (e), kidney (f), brain (g), 
skeletal muscle (h), cardiac muscle (i), and liver 
(j) as well as human A431 (k), and 4 (l), 8 (m), 
16 (n), 32 (o), 64 (p), 128 (q), and 256 (r) ng of 
the  pure calpactin  I complex were  resolved by 
SDS-PAGE  and  transferred  to  nitrocellulose. 
Duplicate blots were treated with antibodies to the 
calpactin I heavy chain (top) or light chain (center 
and bottom)  followed by  12SI-conjugated second 
antibody. (Bottom)  An overexposed  autoradiogram 
of  the middle panel to detect very low level expres- 
sion. Note that the distribution of the light chain 
closely parallels the heavy chain. 
cence microscopy on fixed and permeabilized human fibro- 
blasts (Fig. 4). When cells were fixed directly in organic sol- 
vents, a staining pattern similar to that shown previously with 
polyclonal antibodies to  the calpactin I  complex was  ob- 
served (30, 40, 45). The dominant feature of this distribution 
was the absence of staining in certain areas of the cell previ- 
ously identified as actin-containing stress fibers (45).  This 
staining pattern was  found with methanol/acetone fixation 
(Fig. 4), 4 % formaldehyde fixation (1 h), followed by Triton 
permeabilization (not shown), or formaldehyde fixation fol- 
lowed by methanol/acetone treatment (not shown). This lack 
of stress fiber staining was faintly detectible with polyclonal 
antibodies to the calpactin heavy chain, but this appeared to 
be overlayed  by a more diffuse cytoplasmic staining. A simi- 
lar more diffuse distribution was found when the monoclonal 
antibody to the heavy chain was used (data not shown). Since 
the subcellular distribution of calpactin I has been shown to 
partially overlap that of fodrin,  double staining  was  per- 
formed with the mouse monoclonal antibody to the calpactin 
I light chain and polyclonal rabbit antibodies to fodrin. As 
shown in Fig. 4, the calpactin staining extends further out to 
the edge of the cells by comparison to fodrin, but where the 
two are in the same area a  similar submembrane reticular 
network is stained. 
Previous studies have shown that when fibroblasts are ex- 
tracted with a cytoskeletal stabilizing buffer, a characteristic 
reticular network is stained by antibodies to calpactin I and 
fodrin (30). When this extraction procedure was applied to 
human fibroblasts, a reticular network was visualized using 
antibodies to the calpactin I heavy and light chain but not to 
calpactin II (Fig.  5). 
Antibodies to the calpactin I  light chain were microin- 
jected into living cells grown on coverslips. The cells were 
returned to culture for various times and then fixed and per- 
meabilized with methanol/acetone. The injected cells could 
be easily located using a fluorescently tagged anti-mouse an- 
tibody.  Preliminary experiments showed that the  injected 
anti-light chain antibody was initially localized in a distribu- 
The Journal of Cell Biology, Volume  105, 1987  2114 tion indistinguishable from the pattern when used in conven-  102 
tional immunofluorescence microscopy. Upon longer times 
after injection in some (10%) fibroblasts or most (>60%) 
MDBK cells, the antibody was clustered into large patches 
(Fig. 6). We had the impression that the patches of anti-light 
chain antibody were confined to the plane of the membrane. 
When the antibody to calpactin II was injected in duplicate 
experiments, aggregates were never observed. No abnormal- 
ities in cell shape were apparent in injected cells. Counter- 
staining with a rabbit antibody to the calpactin I heavy chain 
revealed that these antibody patches contained both subunits.  1  ol 
The patches were not stained with anti-calpactin II antibod- 
ies (not shown), consistent with the observation that calpac- 
tin II is not associated with the light chain in vitro.  The  lo2 
anti-light chain antibody aggregates were also not stained 
with antibodies to fodrin (Fig. 6).  .E 
e- 
Calpactin I phosphorylation has been suggested to play an  -~ 
important functional role in transformation by retroviruses  E 
containing  tyrosine-specific protein  kinases  (see  Discus-  "~ 
sion). To assess whether there may be differences in associa- 
tion of calpactin I with either the cytoskeleton or the light  o 
chain, normal and transformed chick fibroblasts were sepa-  o. 
rated into soluble and cytoskeletal fractions and probed with  1  o  1 
antibodies to calpactin I and to phosphotyrosine. As shown 
in Fig. 7 the monoclonal antibodies react strongly with the 
chicken calpactin I subunits. In chick fibroblasts (unlike hu- 
man) the majority of  the calpactin I heavy chain is associated 
with the cytoskeleton. This association is Ca  ++ dependent 
and is similar in both normal and transformed cells. The ex- 
tent of cytoskeletal association of calpactin I is mirrored by 
the relative amount of phosphorylated calpactin in the Tri- 
ton-insoluble pool detected with an antibody to phosphotyro- 
sine (Fig. 7). It should be noted that the gel system and trans- 
fer  conditions have been  optimized  for the  detection of 
caIpactin subunits and hence the antiphosphotyrosine blot 
appears simpler than expected. Under other conditions this 
same  antibody  will  detect  many  other  phosphoproteins 
(Kamps, M., and B. Sefton, manuscript submitted for publi- 
cation). 
Discussion 
The first exogenous substrate identified for the transforming 
tyrosine kinase pp60  s~ was a protein that has been variously 
termed p34, p36, or p39 (11, 12, 34, 44, 46). We have been 
referring to this and related proteins more recently as calpac- 
tin to denote their calcium-, phospholipid-, and actin-binding 
properties.  What was initially thought to be a single poly- 
peptide is now known to be more complex. In a pioneering 
biochemical study on the isolation and characterization of 
calpactin I  (p34)  from chick fibroblasts,  Erikson and co- 
workers (B) noted that two forms of this protein were ob- 
served, with the difference in the two forms being the pres- 
ence of a low molecular weight peptide (estimated then to be 
6,000 but now known to be 11,000). Shortly thereafter Gerke 
and Weber (16) isolated a Ca++-binding cytoskeletal protein 
from intestinal epithelium with subunits of 36 and 11 kD, 
which they referred to as protein I. Gerke and Weber went 
on to show that the 36-kD subunit of protein I is identical 
with the 36-kD substrate of the retroviral tyrosine kinases. 
Further studies by three independent groups (18, 25,  32) 
demonstrated that the light chain is  strikingly related by 
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Figure 3.  Pulse-chase analysis of the calpactin subunits. Human 
fibroblasts were labeled with [35S]methionine for 2 h and chased 
for the indicated times. The amount of radioactivity in soluble and 
cytoskeleton  (insoluble) associated pools of the heavy chain of cal- 
pactin I (A), caipactin II (B), or the calpactin I light chain (C) was 
determined by immunoprecipitation with monoclonal antibodies 
followed by autoradiography. 
amino acid sequence to the S-100 proteins of  brain. Although 
investigators have been studying S-100 for some 20 yr, no 
consensus has emerged as to the role of S-100 in the cell. 
Similarly, the role of the calpactin light chain has been the 
subject of  considerable speculation with little data to support 
it. Studies have shown that the calpactin light chain binds to 
that region of the heavy chain (amino terminus; 26,  35), 
which is phosphorylated by pp6@  ~ (25) and serine/threo- 
nine kinases  (29,  35),  suggesting that this region of the 
heavy chain may be involved in the regulation of calpactins 
functions. The biological property being regulated, however, 
has been elusive. The present study suggests that one regula- 
tory event potentially mediated by the light chain is the as- 
sociation of calpactin I with the membrane skeleton. 
Zokas and Glenney Monoclonal Antibodies  to Calpactin  2115 Figure 4. The subcellular distribution of calpactin I light chain compared with the heavy chain and fodrin in prefixed human fibroblasts as 
revealed by double-label immunofluorescence microscopy. Cells were fixed and permeabilized with -20~  methanol/acetone followed by 
treatment with the monoclonal antibody to the calpactin I light chain (A and C) in combination with polyclonal rabbit antibodies to the 
calpactin I heavy chain (B), or fodrin (D). Reactivity was detected with fluorescein anti-mouse (A and C) and rhodamine anti-rabbit  (B 
and D) immunoglobulin. 
Previous studies using antibodies to calpactin I  isolated 
from chick fibroblasts revealed that calpactin is present in a 
cytoskeletal meshwork under the plasma  membrane,  par- 
tially overlapping the distribution of spectrin in these same 
cells (5, 30, 40, 45). Calpactin has also been found in close 
association with the membrane in tissues (28, 31) and in one 
location, the intestinal epithelial cell,  calpactin was  iden- 
tified in the highly organized brush border region (16, 28), 
a location rich in actin and actin-binding proteins. Many of 
these localization studies relied on antibodies to the calpactin 
I  complex  and  most  of these  antibody  preparations  are 
known to contain significant reactivity with the light chain 
as well as the heavy chain (16, 25). Thus, these studies could 
not distinguish between the location of the complex of heavy 
and  light chains,  for instance,  from the location of either 
monomer alone. In the present study we used monoclonal 
antibodies that  recognize individual  subunits.  The results 
suggest that two functionally distinct populations of calpac- 
tin exist in fibroblasts, each with a distinctive location and 
inherent stability. 
Several lines of evidence suggest that distinct soluble and 
cytoskeletal  forms  of  calpactin  exist.  First,  calpactin  II 
(which is similar in structure and function to calpactin I but 
lacks a light chain [27]) was present exclusively in the deter- 
gent-soluble fraction,  whereas  the  calpactin I  light chain 
(presumably  reflecting the  distribution  of the  calpactin  I 
complex) was only found in the cytoskeletal fraction (Fig. 1). 
The calpactin I heavy chain partitioned equally between de- 
tergent-soluble and particulate fractions, indicating that only 
about  half  is  associated  with  the  cytoskeleton.  Previous 
studies have also noted a heterogeneity in the extractability 
of the calpactin heavy chain (45). 
Immunofluorescence microscopy using antibodies to the 
heavy and light chains revealed that the light chain is present 
exclusively in the membrane structural network. Particularly 
apparent in prefixed ceils is the absence of staining of stress 
The Journal of Cell Biology,  Volume  105, 1987  2116 Figure 5.  Localization of calpactin subunits in human fibroblasts extracted with a cytoskeletal stabilizing buffer. Cells were extracted in 
a detergent containing solution before fixation. Cells were then treated with rabbit antibodies to the calpactin I heavy chain (A and B) 
together with monoclonal antibody reactive with the calpactin I light chain (C) or calpactin II (D). Reactivity was detected with fluorescein 
anti-mouse  (C and D) and rhodamine anti-rabbit  (A and B) immunoglobulin. 
fibers (Fig. 4), a characteristic noted previously and shared 
with the membrane-skeletal protein fodrin (see above). The 
distribution of the heavy chain, by contrast, was more dif- 
fuse.  In  cells  that  were  extracted  with  a  cytoskeleton- 
stabilizing buffer, the light chain was found in the reticular 
network whereas calpactin II was not (Fig. 5). Since this re- 
ticular network is not observed in prefixed cells, it may not 
represent an accurate picture of  the membrane skeleton orga- 
nization in living cells. We favor the notion that the delicate 
membrane filament network collapses upon itself when the 
lipid bilayer is disrupted with detergent. It is possible, for in- 
stance, that calpactin I is associated with both the lipid bi- 
layer and the cytoskeleton (27). When the lipid bilayer is dis- 
rupted, Ca  ++ is needed to stabilize the association with its 
cytoskeletal target. The majority of actin in these extracted 
cells is found in stress fibers, detected using fluorescent phal- 
loidin (not shown). Thus it would appear that this is not sim- 
ply a case of calpactin artifactuaUy binding to actin under 
Zokas and Glenney Monoclonal Antibodies to Calpactin  2117 The Journal of Cell Biology, Volume  105, 1987  2118 Figure  7.  Detection of calpactin I subunits in normal and trans- 
formed chick fibroblasts. Normal (,4) or transformed (B and C) 
fibroblasts were extracted in a cytoskeletal stabilizing buffer con- 
mining 1 mM Ca  ++ (+) or 5 mM EGTA (-), and separated into 
soluble (s) and insoluble (i) fractions. Equivalent amounts were 
subjected to SDS-PAGE, transferred to nitrocellulose, and reacted 
with a mixture of  anti-calpactin I heavy and light chain monoclonal 
antibodies (A and B) or potyclonal rabbit anti-phosphotyrosine an- 
tibodies (C). Blots were further treated with ~2SI-ami-mouse  IgG 
(A and B), or ~2SI-protein A (C), followed by autoradiography. 
extraction conditions containing high Ca  ++  . Consistent with 
this we have found that when MDBK cells are lysed in low 
Ca++-buffer  in the absence of detergent, most of the calpac- 
tin remains with the particulate fraction. The exact targets in 
vivo, however, remain to be determined. 
The immunofluorescence images of heavy and light chain 
subunits in fixed cells appears quite different (Fig. 4). The 
calpactin light chain is firmly associated with a population 
of  the heavy chain as shown clearly by microinjection experi- 
ments (Fig. 6). The antibody to the light chain injected into 
fibroblasts resulted in many cases in the patching of antibody 
within the cells with the concomitant patching of the heavy 
chain of calpactin I (but not calpactin II). We have found no 
cells in which the injected anti-light chain clusters were not 
stained with anti-heavy chain. Interestingly, fodrin was not 
enriched in these patches (Fig. 6), suggesting that the mem- 
brane location of these two structural proteins is not tightly 
linked. A similar result was found with microinjected anti- 
bodies to fodrin (42).  This aggregation of the cytoskeletal 
form of calpactin I should allow us to evaluate the possible 
associations in the cell. 
The third line of evidence for two discrete populations of 
calpactin I comes from experiments on their stability. The 
soluble fraction of the calpactin I heavy chain has a similar 
turnover rate (,x,15 h) as calpactin II, which is also soluble, 
and the cytoskeletal pool of the heavy and light chains of cal- 
pactin I have a similar turnover rate (,'050 h). This difference 
between the turnover rate of the two pools would appear to 
rule out the possibility that calpactin is released after lysing 
the cells, and artifactually rebinding to the cytoskeleton. If 
this were the case, the turnover rate of the two populations 
would be the same. Clearly, two pools of nonexchangeable 
calpactin I  are indicated.  Studies with another membrane 
skeletal protein, spectrin, have resulted in a similar conclu- 
sion, e.g., the soluble fraction of spectrin turns over much 
more quickly than the cytoskeleton-associated  fraction (2, 39). 
In this example, however, the soluble subunits of spectrin 
turned over with a half-life of 50 min (as compared with 15 h 
for soluble calpactins).  A  second analogy to this previous 
work is the regulation of the amount of one subunit in a pro- 
tein complex by a second subunit. In the case of calpactin, 
then, the amount of the light chain is probably limiting in 
cells, similar to the limiting amounts of beta-subunit in the 
spectrin  complex (2).  By  increasing  the  amount of light 
chain,  then,  the heavy chain would be  stabilized and  the 
steady state amount of the heavy chain would increase with- 
out the necessity of changes in the messenger RNA level or 
protein synthesis rate. This may partially explain the appar- 
ent induction of the calpactin heavy chain when chick em- 
bryo fibroblasts are placed in culture. In that study the ac- 
cumulation  of  the  heavy  chain  of calpactin  I  could  be 
correlated with cell adhesion or spreading (4). Similarly, the 
spreading behavior of mammary cells has been correlated 
with the expression of calcium-binding proteins (47), one of 
which is known to be calpactin I. The expression of  the light 
chain may well be the controlling (or stabilizing) element in 
such experiments. Alternatively, other elements in the cell 
such as membrane or cytoskeletal targets may be the stabiliz- 
ing element for the complex of both subunits. The use of the 
antibodies described in this report should help address these 
questions. 
The amount of the calpactin light chain appears  tightly 
coupled to the amount of heavy chain in every tissue exam- 
ined (Fig. 2). This includes tissues with high level expres- 
sion of both subunits  (lung,  intestine),  intermediate levels 
(spleen, muscle), or very low levels (liver, brain). It should 
be noted that the relative level of expression of the calpactin 
I heavy chain detected with a monoclonal antibody used in 
the present study is in substantial agreement with the distri- 
bution reported previously using polyclonal antibodies to the 
chick fibroblast protein (28). In no tissue did we find the ex- 
pression of one subunit in the absence of the other; nor did 
we find vastly different ratios. This finding is interesting in 
light of the recent observation of moderate levels of mRNA 
for the calpactin I light chain in brain tissue (48), whereas 
we find almost no light chain protein in brain (Fig. 2). It is 
Figure 6. Microinjection of antibody to the calpactin light chain. Human fibroblasts (a-d), or MDBK cells (e and f) were injected with 
antibody 1148 and returned to culture for 18 h. Cells were then fixed and permeabilized with methanol/acetone and stained with rabbit 
antibodies to the calpactin I heavy chain (b and f) or fodrin (d). The injected antibody was localized with fluorescein anti-mouse  (a, c, 
and e) and the rabbit antibody with rhodamine anti-rabbit (b, d and  f). Note the patching of injected antibody (a and e) with the copatching 
of the calpactin heavy chain (b and f) in the same cells. 
Zokas and Glenney  Monoclonal Antibodies to Calpactin  2119 likely that the calpactin light chain protein is unstable in the 
absence of the heavy chain and future experiments should 
address this possibility.  We know that in lung and intestine 
calpactin I is found predominantly as a complex of subunits 
(16, 27). Although we have isolated the native monomer from 
lung, the yields are <10 % of the amount of the complex iso- 
lated (27). The precision of the Western-blotting method is 
not high enough to conclude that the ratio of heavy and light 
chains is identical in every tissue, and certainly the tissues 
represent heterogeneous populations of cells that may be ex- 
pressing varying ratios of monomer and complex. Despite 
these limitations, we suggest that no cell type contains sub- 
stantial amounts of the calpactin light chain in the absence 
of heavy chain. In this regard, the situation is quite different 
than with the brain homolog of the calpactin light chain, 
S-100. S-100 is isolated as a dimer of alpha and beta subunits 
(1, 41). Although a fraction of S-100 has been detected as- 
sociated with membranes (8) and S-100 can bind to and acti- 
vate the enzyme aldolase (52),  it is clear that most is not 
complexed with an additional subunit. The significance of 
the 50 % amino acid sequence homology between the calpac- 
tin light chain and S-100 (alpha subunit) remains unclear. 
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